Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SP3 |
| Upstream (Parents) |
|---|
| (<<) ACTB → SP3 |
| (<<) ADRBK1 → SP3 |
| (<<) CASC4 → SP3 |
| (<<) CREB1 → SP3 |
| (<<) EZR → SP3 |
| (<<) FNBP1 → SP3 |
| (<<) HIPK1 → SP3 |
| (<<) IL1A → SP3 |
| (<<) MMP17 → SP3 |
| (<<) PRKAA1 → SP3 |
| (<<) PRKCD → SP3 |
| (<<) RARG → SP3 |
| (<<) RXRB → SP3 |
| (<<) SLC20A1 → SP3 |
| (<<) STK4 → SP3 |
| Downstream (Children) |
|---|
| SP3 → ACTN3 (>>) |
| SP3 → CHST13 (>>) |
| SP3 → CREB5 (>>) |
| SP3 → ENO3 (>>) |
| SP3 → FAM48A (>>) |
| SP3 → HES7 (>>) |
| SP3 → HSPA4 (>>) |
| SP3 → MKNK1 (>>) |
| SP3 → NAB2 (>>) |
| SP3 → POU3F3 (>>) |
| SP3 → PRKAB1 (>>) |
| SP3 → PRSS22 (>>) |
| SP3 → RAF1 (>>) |
| SP3 → ST3GAL6 (>>) |
| SP3 → VIM (>>) |
